Key statistics
As of last trade Insulet Corp (P2OD34:SAO) traded at 52.05, -3.07% below its 52-week high of 53.70, set on Nov 11, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 51.90 |
---|---|
High | 52.55 |
Low | 51.90 |
Bid | 51.10 |
Offer | 51.50 |
Previous close | 52.05 |
Average volume | 435.67 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Nov 21 2024 15:17 GMT.
More ▼
Press releases
- Insulet Announces Omnipod® 5 System is Now Compatible with Abbott’s FreeStyle Libre 2 Plus Sensor in the U.S.
- Insulet to Present at Upcoming Investor Conferences
- Insulet Reports Third Quarter 2024 Revenue Increase of 26% Year-Over-Year (25% Constant Currency¹)
- Insulet Announces Array of Activities to Support National Diabetes Awareness Month and World Diabetes Day in November
- Omnipod® 5 App for iPhone® Now Fully Available in the United States
- Masimo Appoints Timothy Scannell and Wendy Lane to Board of Directors
- Insulet to Announce Third Quarter 2024 Financial Results on November 7, 2024
- Omnipod® 5 Automated Insulin Delivery System is now FDA-cleared for People with Type 2 Diabetes
More ▼